Tmunity Therapeutics Company
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Technology:
CAR-T
Industry:
CAR-T
Headquarters:
Philadelphia, Pennsylvania, United States
Founded Date:
2015-01-01
Funding Status:
Late Stage Venture
Investors Number:
25
Total Funding:
230000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-10-31
Last Funding Type:
Series B
Register and Claim Ownership